title: Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease.
abstract: The effects of end-stage liver disease and orthotopic liver transplantation on components that modulate cholesterol esterification in plasma were assessed. In comparison with healthy controls, patients with end-stage liver disease had significantly decreased concentrations of lecithin-cholesterol acyltransferase mass, apolipoprotein A-1, total phospholipids, and both total and esterified cholesterol. Elevated phosphatidylcholine and reduced lysophosphatidylcholine fractions indicated impairment of cholesterol esterification by lecithin-cholesterol acyltransferase. Constituent fatty acids of the patients' phospholipids and cholesterol esters manifested increased saturation and a concomitant reduction of polyunsaturated fatty acids, indicative of impaired hepatic elongation and desaturation of essential fatty acids. By the third month after hepatic replacement, the plasma concentrations of total cholesterol, phospholipids, lecithin-cholesterol acyltransferase, and apolipoprotein A-1 were comparable to those of the healthy subjects. Despite the improvement in cholesterol esterification and the rapid normalization of the enzyme and cofactor involved in this process, the percentage of phosphatidylcholine remained significantly higher and the percentages of lysophosphatidylcholine and esterified cholesterol remained significantly lower than in the healthy subjects at 6 mo. Phospholipid and cholesterol ester fatty acid patterns attained normalcy by the sixth month after transplant. We conclude that hepatic transplantation effectively restores cholesterol and essential fatty acid metabolism in patients with end-stage liver disease.
authors.affiliation: Laboratory of Nutrition and Infection, New England Deaconess Hospital/Harvard Medical School, Boston, Massachusetts.
authors.forename: J D
authors.initials: JD
authors.lastname: Palombo
authors.forename: S M
authors.initials: SM
authors.lastname: Lopes
authors.forename: S H
authors.initials: SH
authors.lastname: Zeisel
authors.forename: R L
authors.initials: RL
authors.lastname: Jenkins
authors.forename: J J
authors.initials: JJ
authors.lastname: Albers
authors.forename: G L
authors.initials: GL
authors.lastname: Blackburn
authors.forename: B R
authors.initials: BR
authors.lastname: Bistrian
mesh_terms: D000328:Adult; D001054:Apolipoproteins A / Q000097:blood; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D002788:Cholesterol Esters / Q000097:blood; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood; D010743:Phospholipids / Q000097:blood
chemical_list: D001054:Apolipoproteins A; D002788:Cholesterol Esters; D005227:Fatty Acids; D010743:Phospholipids; D002784:Cholesterol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase